Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Maravai Lifesciences Holdings (MRVI) Return on Invested Capital (2021 - 2025)

Historic Return on Invested Capital for Maravai Lifesciences Holdings (MRVI) over the last 5 years, with Q3 2025 value amounting to 0.26%.

  • Maravai Lifesciences Holdings' Return on Invested Capital fell 3800.0% to 0.26% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.26%, marking a year-over-year decrease of 3800.0%. This contributed to the annual value of 0.21% for FY2024, which is 2200.0% down from last year.
  • Maravai Lifesciences Holdings' Return on Invested Capital amounted to 0.26% in Q3 2025, which was down 3800.0% from 0.4% recorded in Q2 2025.
  • In the past 5 years, Maravai Lifesciences Holdings' Return on Invested Capital registered a high of 0.5% during Q1 2022, and its lowest value of 0.4% during Q2 2025.
  • In the last 5 years, Maravai Lifesciences Holdings' Return on Invested Capital had a median value of 0.14% in 2023 and averaged 0.14%.
  • Its Return on Invested Capital has fluctuated over the past 5 years, first soared by 2700bps in 2022, then tumbled by -4100bps in 2025.
  • Quarter analysis of 5 years shows Maravai Lifesciences Holdings' Return on Invested Capital stood at 0.48% in 2021, then decreased by -23bps to 0.36% in 2022, then plummeted by -99bps to 0.01% in 2023, then crashed by -4590bps to 0.23% in 2024, then dropped by -10bps to 0.26% in 2025.
  • Its Return on Invested Capital was 0.26% in Q3 2025, compared to 0.4% in Q2 2025 and 0.31% in Q1 2025.